Evidence map›Paper›PMID 31055499›Full record

ArticleHeart (British Cardiac Society)2019

Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction.

Daniel Lindholm, Giovanna Sarno, David Erlinge, Bodil Svennblad, Lars Pål Hasvold, Magnus Janzon, Tomas Jernberg, Stefan K James

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Heart (British Cardiac Society), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05024864 (HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05024864 naactive not recruitingnot on this mapstarted 2021, after this paper: background citation

HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction (HELP-MI SWEDEHEART)

TypeinterventionalSponsorKarolinska InstitutetRan2021 to 2030Enrolled20,000ConditionsMyocardial Infarction, Helicobacter Pylori Infection, GastroIntestinal Bleeding, Cardiovascular DiseasesArmsUrea breath test (UBT)
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial Infarction.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  2. Prognostic value of risk factors for ischaemic and major bleeding events in chronic coronary syndrome: a SWEDEHEART registry study.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  3. Review
  4. Design and rationale of the South-East Netherlands Heart Registry (ZON-HR).Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  5. Article
  6. Review
  7. [Long-term course of heart disease: How can psychosocial care be improved?]Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2022
    Review
  8. Dual antiplatelet therapy for reduction in mortality in patients with acute and chronic coronary syndromes.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2021
    Review
  9. Observational
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Daniel LindholmAstraZeneca R&D, Gothenburg, Sweden.
Giovanna SarnoDepartment of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
David ErlingeDepartment of Cardiology, Lund University, Lund, Sweden.
Bodil SvennbladUppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Lars Pål HasvoldMedical Department, AstraZeneca, Sodertalje, Sweden.ORCID 0000-0002-9088-4035
Magnus JanzonDepartment of Medical and Health Sciences, Department of Cardiology, Linköping University, Linköping, Sweden.ORCID 0000-0002-9375-5087
Tomas JernbergDepartment of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.
Stefan K JamesUppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Uppsala University · SEAstraZeneca (Sweden) · SEKarolinska University Hospital · SELinköping University · SELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn patients with myocardial infarction (MI), risk factors for bleeding and ischaemic events tend to overlap, but the combined effects of these factors have scarcely been studied in contemporary real-world settings. We aimed to assess the combined associations of established risk factors using nationwide registries.

methodsUsing the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies registry, patients with invasively managed MI in 2006-2014 were included. Six factors were assessed in relation to cardiovascular death (CVD)/MI/stroke, and major bleeding: age ≥65, chronic kidney disease, diabetes, multivessel disease, prior bleeding and prior MI.

resultsWe studied 100 879 patients, of whom 20 831 (20.6%) experienced CVD/MI/stroke and 5939 (5.9%) major bleeding, during 3.6 years median follow-up. In adjusted Cox models, all factors were associated with CVD/MI/stroke, and all but prior MI were associated with major bleeding. The majority (53.5%) had ≥2 risk factors. With each added risk factor, there was a marked but gradual increase in incidence of the CVD/MI/stroke. This was seen also for major bleeding, but to a lesser extent, largely driven by prior bleeding as the strongest risk factor.

conclusionsThe majority of patients with MI had two or more established risk factors. Increasing number of risk factors was associated with higher rate of ischaemic events. When excluding patients with prior major bleeding, bleeding incidence rate increased only minimally with increasing number of risk factors. The high ischaemic risk in those with multiple risk factors highlights an unmet need for additional preventive measures.

Indexed as

AgedFemaleHemorrhageHumansIncidenceMaleMiddle AgedMyocardial InfarctionRegistriesRetrospective StudiesRisk FactorsStrokeSurvival RateSwedenacute coronary syndromesrisk factors

Identifiers

PMID31055499
PMCPMC6662954
OpenAlexW2943777086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.